Brief: Caplin Point Laboratories Says USFDA Issued Zero Form 483 Post Inspection At Gummudipoondi Site
07/09/2018 04:55
Sept 7 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* US FDA CONDUCTED INSPECTION AT STERILE INJECTABLE SITE (CP
- IV)
AT GUMMUDIPOONDI FROM AUG 30 TO SEPTEMBER 06
* THERE WERE ZERO FORM 483 AFTER INSPECTION
Source text: http://bit.ly/2NV6DS5
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees